A functional RNAi screen for regulators of receptor tyrosine kinase and ERK signalling

Nature

Volumn 444, Issue 7116, 2006, Pages 230-234

  Friedman, Adam ^a   Perrimon, Norbert ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL CULTURE; BIOASSAY; CARCINOGENS; DRUG PRODUCTS; MUTAGENESIS; RNA; SIGNAL PROCESSING; SIGNALING;

EXTRACELLULAR-SIGNAL- REGULATED KINASES (ERK); FATE DETERMINATION; METAZOAN DEVELOPMENT;

SCREENING;

ANTINEOPLASTIC AGENT; CYTOTOXIC AGENT; MITOGEN ACTIVATED PROTEIN KINASE; REGULATOR PROTEIN; RNA; TYROSINE KINASE RECEPTOR;

BIOLOGICAL DEVELOPMENT; DISEASE; ENZYME ACTIVITY; GENE; METAZOAN; PHENOTYPE; PROTEIN; RNA;

ARTICLE; CELL ACTIVATION; CELL ASSAY; CELL TYPE; CLASSIFICATION; DROSOPHILA; DRUG TARGETING; ENZYME ACTIVATION; ENZYME ISOLATION; GENOME ANALYSIS; HIGH THROUGHPUT SCREENING; MAMMAL CELL; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; RNA INTERFERENCE; SIGNAL TRANSDUCTION; VALIDATION PROCESS;

MAMMALIA; METAZOA;

EID: 33750887331     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05280     Document Type: Article

References (30)

1. Krause, D. S. & Van Etten, R. A. Tyrosine kinases as targets for cancer therapy. N. Engl. J. Med. 353, 172-187 (2005).
2. Hilger, R. A., Scheulen, M. E. & Strumberg, D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 25, 511-518 (2002).
3. DasGupta, R., Kaykas, A., Moon, R. T. & Perrimon, N. Functional genomic analysis of the Wnt-wingless signaling pathway. Science 308, 826-833 (2005).
4. Gabay, L., Seger, R. & Shilo, B. Z. MAP kinase in situ activation atlas during Drosophila embryogenesis. Development 124, 3535-3541 (1997).
5. Clemens, J. C. et al. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc. Natl Acad. Sci. USA 97, 6499-6503 (2000).
6. Kiger, A. et al. A functional genomic analysis of cell morphology using RNA interference. J. Biol. 2, 27 doi: 10.1186/1475-4924-2 (1 October 2003).
7. York, R. D. et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 392, 622-626 (1998).
8. Luschnig, S., Krauss, J., Bohmann, K., Desjeux, I. & Nusslein-Volhard, C. The Drosophila SHC adaptor protein is required for signaling by a subset of receptor tyrosine kinases. Mol. Cell 5, 231-241 (2000).
9. Arevalo, J. C., Pereira, D. B., Yano, H., Teng, K. K. & Chao, M. V. Identification of a switch in neurotrophin signaling by selective tyrosine phosphorylation. J. Biol. Chem. 281, 1001-1007 (2006).
10. Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635-647 (2005).
11. Roignant, J-Y., Hamel, S., Janody, F. & Treisman, J. E. The novel SAM domain protein Aveugle is required for Raf activation in the Drosophila EGF receptor signaling pathway. Genes Dev. 20, 795-806 (2006).
12. Westbrook, T. F. et al. Agenetic screen for candidate tumor suppressors identifies REST. Cell 121, 837-848 (2005).
13. Chang, F. et al. Regulation of cell cycle progression and apoptosis by the Ras/Raf/MEK/ERK pathway (Review). Int. J. Oncol. 22, 469-480 (2003).
14. Asha, H. et al. Analysis of Ras-induced overproliferation in Drosophila hemocytes. Genetics 163, 203-215 (2003).
15. Nebreda, A. R., Gannon, J. V. & Hunt, T. Newly synthesized protein(s) must associate with p34cdc2 to activate MAP kinase and MPF during progesterone-induced maturation of Xenopus oocytes. EMBO J. 14, 5597-5607 (1995).
16. Chen, X. et al. Cyclin D-Cdk4 and cyclin E-Cdk2 regulate the Jak/STAT signal transduction pathway in Drosophila. Dev. Cell 4, 179-190 (2003).
17. Yang, S. H., Sharrocks, A. D. & Whitmarsh, A. J. Transcriptional regulation by the MAP kinase signaling cascades. Gene 320, 3-21 (2003).
18. Lipsick, J. S. synMuv verité-Myb comes into focus. Genes Dev. 18, 2837-2844 (2004).
19. Jordan, K. C. et al. Genome wide analysis of transcript levels after perturbation of the EGFR pathway in the Drosophila ovary. Dev. Dyn. 232, 709-724 (2005).
20. Irie, H. Y. et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J. Cell Biol. 171, 1023-1034 (2005).
21. Zimmermann, S. & Moelling, K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744 (1999).
22. Puig, O. & Tjian, R. Transcriptional feedback control of insulin receptor by dFOXO/FOXO1. Genes Dev. 19, 2435-2446 (2005).
23. Roy, F., Laberge, G., Douziech, M., Ferland-McCollough, D. & Therrien, M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16, 427-438 (2002).
24. Dan, I., Watanabe, N. M. & Kusumi, A. The Ste20 group kinases as regulators of MAP kinase cascades. Trends Cell Biol. 11, 220-230 (2001).
25. Halfar, K., Rommel, C., Stocker, H. & Hafen, E. Ras controls growth, survival and differentiation in the Drosophila eye by different thresholds of MAP kinase activity. Development 128, 1687-1696 (2001).
26. Ory, S., Zhou, M., Conrads, T. P., Veenstra, T. D. & Morrison, D. K. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr. Biol. 13, 1356-1364 (2003).
27. Sung, V. et al. The Ste20 kinase MST4 plays a role in prostate cancer progression. Cancer Res. 63, 3356-3363 (2003).
28. Baril, C. & Therrien, M. Alphabet, a Ser/Thr phosphatase of the protein phosphatase 2C family, negatively regulates RAS/MAPK signaling in Drosophila. Dev. Biol. 294, 232-245 (2006).
29. Cheng, A., Kaldis, P. & Solomon, M. J. Dephosphorylation of human cyclin-dependent kinases by protein phosphatase type 2Ca and b2 isoforms. J. Biol. Chem. 275, 34744-34749 (2000).
30. Takekawa, M., Maeda, T. & Saito, H. Protein phosphatase 2Calpha inhibits the human stress-responsive p38 and JNK MAPK pathways. EMBO J. 17, 4744-4752 (1998).